David M. Gershenson, MD

University of Texas MD Anderson Cancer Center

GershensonDr. Gershenson is Professor and J. Taylor Wharton, M.D., Distinguished Chair in Gynecologic Oncology in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center, where he joined the faculty in 1979 after completing his fellowship training. His major research focus is on clinical and translational aspects of rare ovarian tumors.

Since 1999, he has served as Co-Principal Investigator of MD Anderson’s NCI-funded SPORE in Ovarian Cancer and, more recently, as Co-Project Leader of Project 3, “Personalized Therapy for Women with Low-Grade Serous Carcinoma of the Ovary.” Dr. Gershenson also serves as Chair of the Gynecologic Oncology Group’s (GOG) Rare Tumor Committee and as a member of the GOG Protocol Development Committee. He is a Co-Chair of the NCI’s Gynecologic Cancer Steering Committee.

From 2009-2015, he served as Chairman of the Foundation for Women’s Cancer. Since 2006, he has served as a Director of the American Board of Obstetrics and Gynecology. Dr. Gershenson is also Editor Emeritus of the journal Gynecologic Oncology.

Spotlight

Staff and supporters at the Foundation are thrilled to welcome new Chairman David Mutch, MD, FACOG. Read Dr. Mutch’s bio here.

Awareness

Radiation side effects can cause their own symptoms and suffering. Cervical cancer survivor @tranetteiswrite reports on the issue in her new piece.

Research

The Foundation for Women’s Cancer is pleased to announce the recipients of its 2014-2015 Research Grant and Prizes. View the PDF.

Education

The next Ovarian Cancer Survivors Course is May 8 in Orlando, FL. For more information, click here.